BrightSpring Q2 FY26 net income more than doubled to USD 87 million; revenue rises 23% to USD 3.87 billion

• BrightSpring posted Q2 2026 net revenue of USD 3.87 billion, up 23% year over year, with net income of USD 87 million.
• Non-GAAP adjusted EBITDA climbed 44.2% from a year earlier to USD 206 million, following the March divestiture of Community Living.
• Pharmacy Solutions revenue rose 22% to USD 3.41 billion, while Provider Services revenue increased 30% to USD 466 million.
• Leverage narrowed to 2.15x at June 30, 2026; BrightSpring completed a USD 300 million paydown and modification of the First Lien Facility.
• CEO Jon Rousseau cited disciplined operational execution and high-quality care; full-year revenue guidance increased to USD 15.1-15.43 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brightspring Health Services Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310600PRIMZONEFULLFEED9801382) on July 31, 2026, and is solely responsible for the information contained therein.